Trial reportPharmacy world & science : PWS2008
Description of pharmacist interventions during physician-pharmacist co-management of hypertension.
Trial report in Pharmacy world & science : PWS, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
33 citing papers in PubMed, 2 syntheses or guidelines pooled it, 82 citations in OpenAlex.
- Nurse Practitioner-Physician Comanagement: A Theoretical Model to Alleviate Primary Care Strain.Annals of family medicine · 2018Pooled it
- Team-based care and improved blood pressure control: a community guide systematic review.American journal of preventive medicine · 2014Pooled it
- Effects of Pharmacist Intervention on Community Control of Hypertension: A Randomized Controlled Trial in Zunyi, China.Global health, science and practice · 2021Trial
- A pharmacist intervention for monitoring and treating hypertension using bidirectional texting: PharmText BP.Contemporary clinical trials · 2020Trial
- Pharmacist Intervention for Blood Pressure Control in Patients with Diabetes and/or Chronic Kidney Disease.Pharmacotherapy · 2018Trial
- Cost-Effectiveness of a Physician-Pharmacist Collaboration Intervention to Improve Blood Pressure Control.Hypertension (Dallas, Tex. : 1979) · 2015Trial
- Pharmacist intervention for blood pressure control: medication intensification and adherence.Journal of the American Society of Hypertension : JASH · 2015Trial
- Cluster-randomized trial of a physician/pharmacist collaborative model to improve blood pressure control.Circulation. Cardiovascular quality and outcomes · 2015Trial
- Pharmacist-physician comanagement of hypertension and reduction in 24-hour ambulatory blood pressures.Archives of internal medicine · 2010Trial
- Why physicians do not prescribe a thiazide diuretic.Journal of clinical hypertension (Greenwich, Conn.) · 2010Trial
- A cluster-randomized effectiveness trial of a physician-pharmacist collaborative model to improve blood pressure control.Circulation. Cardiovascular quality and outcomes · 2010Trial
- Effect of self-efficacy and social support on adherence to antihypertensive drugs.Pharmacotherapy · 2010Trial
- Deterioration of blood pressure control after discontinuation of a physician-pharmacist collaborative intervention.Pharmacotherapy · 2010Trial
- Reduction in adverse symptoms as blood pressure becomes controlled.Pharmacotherapy · 2008Trial
- Instrumental variable methods to assess quality of care the marginal effects of process-of-care on blood pressure change and treatment costs.Research in social & administrative pharmacy : RSAPTrial
- A cluster randomized trial to evaluate a centralized remote clinical pharmacy service in large, health system primary care clinics.Journal of the American College of Clinical Pharmacy : JACCP · 2021Article
- Targeting of uncontrolled hypertension in the emergency department (TOUCHED): Design of a randomized controlled trial.Contemporary clinical trials · 2021Article
- High blood pressure readings on in-store machines: a qualitative study of the perspective of pharmacy staff.Journal of pharmaceutical policy and practice · 2021Article
- An evaluation of the role of practice pharmacists in Australia: a mixed methods study.International journal of clinical pharmacy · 2019Article
- Michigan Pharmacists Transforming Care and Quality: Developing a Statewide Collaborative of Physician Organizations and Pharmacists to Improve Quality of Care and Reduce Costs.Journal of managed care & specialty pharmacy · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 2 institutions in 1 country.
Funding
Abstract
objectiveThe aim of this study is to describe recommendations made by clinical pharmacists when co-managing hypertension with physicians.
settingTwo family medicine clinics at a major teaching hospital in the mid-western United States.
methodThis report details the specific recommendations made by pharmacists during a prospective randomized controlled clinical trial. Patients with uncontrolled hypertension were enrolled in a 9-month intensive pharmacist-physician co-management study. Clinical pharmacists saw patients at baseline, 2, 4, 6, and 8 month visits. Optional visits were allowed between required visits.
main outcome measureFor this analysis, pharmacist recommendations were grouped. Physician acceptance of the pharmacists' recommendations was also evaluated.
resultsData from 101 patients were included and analyzed in this study. Changes in drug therapy were recommended 267 times for these 101 patients. Most recommendations for a change in treatment involved adding a new antihypertensive medication (46.4%) or increasing a dose (33.3%). The majority of pharmacist recommendations to modify drug therapy were made at the baseline visit (41.6%), with 76.8% of recommendations made by the 2 month visit. Physicians accepted and implemented 95.9% of the 267 pharmacist recommendations to modify drug therapy. Pharmacists recommended no change in the treatment plan 361 times, most often because the patient's blood pressure (BP) had achieved the goal. Average BP decreased from 153.1+/-10.0/84.9+/-12.0 mmHg (average+/-SD) at baseline to 124.2+/-9.7/74.7+/-9.6 mmHg (P<0.001) at the end of 9 months, with 89.1% (P<0.001) of patients reaching their BP goal.
conclusionPharmacist recommendations for alterations in drug therapy generally occurred early in the course of the study and were largely to intensify therapy through higher dosages or additional medications. Pharmacist-physician co-management of BP is effective at reducing BP and improving BP control rates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.